Concepedia

MV Blagosklonny

MB

6

Publications

363

Citations

6

H-Index

1999

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

MV Blagosklonny is an author at National Cancer Institute specializing in medicine, pharmacology, and cell biology.

Top concepts

Publications per year

1999–2010

6

Publications

6

The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy

MV Blagosklonny, Tito Fojo, J-S Kim et al. · Leukemia · 2001 · 123 citations

, , +7

Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells

MV Blagosklonny · Leukemia · 2001 · 88 citations

, , +10

Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells

MV Blagosklonny, Yoshiro Chuman, Tito Fojo · Leukemia · 1999 · 73 citations

, , +7

Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal

MV Blagosklonny · Leukemia · 1999 · 39 citations

, , +9

Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells

Edward Kyle, Sajni Patel, Franck Housseau et al. · Prostate Cancer and Prostatic Diseases · 2001 · 29 citations

, , +6

Rows per page

1–5 of 6